Avacta Group PLC

AVCT · LSE · Healthcare / Biotechnology

59.00GBX-2.60 (-4.22%)

Price History

Full chart

Market Stats

Previous Close61.60

Open59.25

Day Range56.00 – 60.00

52-Week Range48.00 – 92.00

Volume1.35M

Market Cap329.01M

P/E (TTM)0.00

Forward P/E113.64

EPS-0.09

Dividend Yield0.00%

Beta-0.11

50-Day Avg69.74

200-Day Avg68.35

About

Avacta Group Plc, together with its subsidiaries, engages in the development of cancer therapies in the United Kingdom, South Korea, and internationally. The company's lead product candidate is AVA6000, a peptide drug conjugate form of doxorubicin, which is an approved cancer drug with known severe toxicities. It also develops AVA6103, a peptide drug conjugate technology designed to deliver exatecan, a potent topoisomerase I inhibitor directly to tumors while limiting the exposure of the released exatecan in normal tissues; and AVA7100 that drives localization to fibroblast activation protein expressing tumors. The company was incorporated in 2003 and is headquartered in London, the United Kingdom.

Company Details

SectorHealthcare
IndustryBiotechnology
CEODr. Christina Marie Coughlin B.S., M.D., Ph.D.
Employees81
HeadquartersScale Space White City Imperial College Campus, London, United Kingdom, W12 7RZ, UK
Websitehttps://avacta.com

Leadership

Dr. Christina Marie Coughlin B.S., M.D., Ph.D.CEO & Executive Director · b. 1970
Mr. Brian M. HahnCFO & Company Secretary · b. 1974
Ms. Karen HarrisonChief Operating Officer
Mr. Francis WilsonChief Scientific Officer
Ms. Emma WrightGroup In-House Counsel
Mr. Michael VinegradGroup Communications Director
Mr. R. Craig Slater FCAChief Operating Officer of Diagnostics · b. 1964
Mr. David WilsonChief Commercial Officer of Diagnostics
Ms. Anne McGurkJoint Managing Director of Launch Diagnostics
Mr. Sebastien GoenenChief Operating Officer of Coris BioConcept

Financials

Income Statement

Currency: GBP	2001-04-30	2002-04-30	2003-04-30	2004-04-30	2005-04-30	2006-04-30	2007-07-31	2008-07-31	2009-07-31	2010-07-31	2011-07-31	2012-07-31	2013-07-31	2014-07-31	2015-07-31	2016-07-31	2017-07-31	2018-07-31	2019-07-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: GBP	2001-04-30	2002-04-30	2003-04-30	2004-04-30	2005-04-30	2006-04-30	2007-07-31	2008-07-31	2009-07-31	2010-07-31	2011-07-31	2012-07-31	2013-07-31	2014-07-31	2015-07-31	2016-07-31	2017-07-31	2018-07-31	2019-07-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	9.00K	11.00K	-	19.00K	313.00K	4.00K	169.60K	466.00K	944.00K	2.07M	2.44M	3.13M	2.70M	3.18M	1.81M	2.17M	2.73M	2.76M	3.89M	2.14M	2.94M	9.65M	2.85M	113.00K	113.00K
Growth (%)	-	+22.22%	-	-	+1547.37%	-98.72%	+4140.00%	+174.76%	+102.58%	+118.96%	+18.29%	+28.02%	-13.74%	+17.78%	-42.99%	+19.42%	+26.33%	+1.02%	+40.79%	-44.89%	+37.17%	+228.22%	-70.47%	-96.04%	0.00%
Cost of Revenue	2.00K	7.00K	-	84.00K	224.00K	1.00K	-	-	96.00K	-	3.38M	1.62M	1.19M	1.14M	1.01M	2.14M	2.52M	2.93M	3.80M	3.12M	5.44M	2.41M	15.00K	1.50M	1.28M
Gross Profit	7.00K	4.00K	-	-65.00K	89.00K	3.00K	212.00K	466.00K	848.00K	2.07M	-933.00K	1.51M	1.51M	2.04M	802.00K	24.00K	211.00K	-164.00K	86.12K	-973.00K	-2.50M	7.24M	2.84M	113.00K	113.00K
Gross Margin	77.78%	36.36%	-	-342.11%	28.43%	75.00%	125.00%	100.00%	89.83%	100.00%	-38.16%	48.27%	56.04%	64.12%	44.24%	1.11%	7.71%	-5.94%	2.21%	-45.38%	-85.07%	75.03%	99.47%	100.00%	100.00%
Operating Expense	-142.00K	-156.00K	-	272.00K	-163.00K	-130.00K	1.20M	-1.19M	-2.01M	41.00K	-2.06M	3.30M	3.39M	3.85M	3.96M	5.69M	8.18M	9.28M	12.80M	15.88M	26.55M	32.74M	24.84M	32.67M	30.37M
Operating Income	149.00K	160.00K	-100.00K	-337.00K	252.00K	133.00K	-988.80K	1.65M	2.86M	2.03M	1.13M	-1.79M	-1.87M	-1.81M	-3.16M	-5.66M	-7.97M	-9.45M	-12.71M	-16.85M	-29.05M	-25.49M	-22.00M	-32.56M	-30.25M
Operating Margin	1655.56%	1454.55%	-	-1773.68%	80.51%	3325.00%	-583.02%	354.59%	302.65%	98.02%	46.01%	-57.25%	-69.37%	-57.01%	-174.30%	-261.62%	-291.41%	-341.95%	-326.82%	-786.01%	-987.90%	-264.09%	-771.83%	-28812.39%	-26772.57%
EBITDA	-98.00K	-119.00K	-75.00K	-291.00K	-986.00K	-158.00K	-974.20K	-1.51M	-2.74M	-1.82M	-875.00K	-1.40M	-1.51M	-1.52M	-2.67M	-4.42M	-6.40M	-8.36M	-8.40M	-16.40M	-26.69M	-34.78M	-14.12M	-17.62M	-28.96M
EBITDA Margin	-1088.89%	-1081.82%	-	-1531.58%	-315.02%	-3950.00%	-574.41%	-324.46%	-289.83%	-87.91%	-35.79%	-44.86%	-55.78%	-47.74%	-147.55%	-204.06%	-233.93%	-302.42%	-215.82%	-764.97%	-907.51%	-360.28%	-495.16%	-15596.46%	-25624.78%
Net Income	-150.00K	-166.00K	-111.00K	-298.00K	-1.10M	-107.00K	-1.22M	-1.47M	-2.69M	-1.88M	-591.00K	-1.11M	-1.52M	-1.49M	-10.14M	-4.65M	-6.37M	-8.83M	-11.02M	-18.89M	-26.32M	-36.94M	-24.95M	-52.84M	-38.38M
Net Income Margin	-1666.67%	-1509.09%	-	-1568.42%	-352.40%	-2675.00%	-718.75%	-315.11%	-284.43%	-90.90%	-24.17%	-35.34%	-56.33%	-46.92%	-559.24%	-214.64%	-232.80%	-319.54%	-283.34%	-881.11%	-894.80%	-382.68%	-875.03%	-46761.95%	-33961.06%
R&D	-	-	-	30.00K	-	-	-	862.00K	858.00K	161.00K	192.00K	52.00K	87.00K	728.00K	2.47M	1.50M	2.03M	2.73M	5.55M	8.89M	13.48M	11.10M	13.11M	14.27M	16.91M
R&D as % of Total Revenue	-	-	-	157.89%	-	-	-	184.98%	90.89%	7.79%	7.85%	1.66%	3.22%	22.89%	136.29%	69.28%	74.11%	98.81%	142.62%	414.69%	458.35%	114.99%	459.77%	12624.78%	14963.72%
Interest Expense	1.00K	6.00K	11.00K	6.00K	4.00K	0	2.00K	4.00K	3.00K	2.00K	1.00K	0	0	0	0	0	0	0	69.18K	89.00K	128.00K	2.70M	15.30M	10.09M	7.05M
Interest Expense % of Total Revenue	11.11%	54.55%	-	31.58%	1.28%	0.00%	1.18%	0.86%	0.32%	0.10%	0.04%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.78%	4.15%	4.35%	27.98%	536.58%	8930.09%	6238.05%

Balance Sheet

Currency: GBP	2001-04-30	2002-04-30	2003-04-30	2004-04-30	2005-04-30	2006-04-30	2007-07-31	2008-07-31	2009-07-31	2010-07-31	2011-07-31	2012-07-31	2013-07-31	2014-07-31	2015-07-31	2016-07-31	2017-07-31	2018-07-31	2019-07-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: GBP	2001-04-30	2002-04-30	2003-04-30	2004-04-30	2005-04-30	2006-04-30	2007-07-31	2008-07-31	2009-07-31	2010-07-31	2011-07-31	2012-07-31	2013-07-31	2014-07-31	2015-07-31	2016-07-31	2017-07-31	2018-07-31	2019-07-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	212.00K	179.00K	182.00K	1.38M	215.00K	33.00K	2.85M	5.14M	9.05M	11.22M	12.34M	18.49M	17.66M	31.05M	21.40M	37.55M	31.55M	23.45M	-	28.41M	67.46M	47.00M	92.65M	73.19M	48.27M	29.42M
Total Liabilities	575.00K	708.00K	412.00K	348.00K	194.00K	19.00K	216.00K	275.00K	758.00K	1.25M	899.00K	1.53M	2.10M	2.21M	2.27M	1.70M	1.66M	2.04M	-	2.60M	5.53M	5.78M	74.21M	51.39M	38.99M	26.94M
Total Equity	-363.00K	-529.00K	-230.00K	1.03M	21.00K	14.00K	2.63M	4.87M	8.30M	9.97M	11.44M	16.96M	15.55M	28.84M	19.13M	35.86M	29.89M	21.41M	-	25.81M	61.93M	41.22M	18.44M	21.80M	9.28M	2.48M
Cash	12.00K	22.00K	3.00K	429.00K	169.00K	32.00K	2.53M	1.10M	878.00K	1.43M	1.77M	4.19M	582.00K	11.48M	7.33M	9.52M	9.17M	5.22M	-	8.79M	27.89M	26.19M	41.78M	16.63M	12.87M	16.86M
Total Debt	552.00K	668.00K	324.00K	285.00K	125.00K	1.00K	52.00K	41.00K	29.00K	16.00K	4.00K	-	-	-	-	-	-	-	-	823.00K	2.04M	1.70M	62.94M	23.51M	22.93M	14.92M
Net Debt	540.00K	646.00K	321.00K	-144.00K	-44.00K	-31.00K	-2.48M	-1.06M	-849.00K	-1.42M	-1.77M	-4.19M	-582.00K	-11.48M	-7.33M	-9.52M	-9.17M	-5.22M	-	-7.96M	-25.85M	-24.49M	21.16M	6.89M	10.06M	-1.94M

Cash Flow

Currency: GBP	2001-04-30	2002-04-30	2003-04-30	2004-04-30	2005-04-30	2006-04-30	2007-07-31	2008-07-31	2009-07-31	2010-07-31	2011-07-31	2012-07-31	2013-07-31	2014-07-31	2015-07-31	2016-07-31	2017-07-31	2018-07-31	2019-07-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: GBP	2001-04-30	2002-04-30	2003-04-30	2004-04-30	2005-04-30	2006-04-30	2007-07-31	2008-07-31	2009-07-31	2010-07-31	2011-07-31	2012-07-31	2013-07-31	2014-07-31	2015-07-31	2016-07-31	2017-07-31	2018-07-31	2019-07-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-138.00K	-106.00K	-42.00K	-407.00K	-82.00K	-139.00K	-1.25M	-1.29M	-2.80M	-1.74M	-596.00K	-711.00K	-1.38M	-838.00K	-2.52M	-4.23M	-4.24M	-5.47M	-13.02M	-10.64M	-20.51M	-16.43M	-14.87M	-23.60M	-24.75M
Investing Cash Flow	32.00K	-	-42.00K	-42.00K	-8.00K	26.00K	115.00K	-124.00K	2.52M	-1.00M	-1.02M	-1.76M	-2.23M	-2.80M	-1.66M	-14.63M	3.87M	1.48M	-2.53M	-21.90M	18.70M	-25.04M	-9.00M	-1.43M	9.90M
Financing Cash Flow	116.00K	116.00K	57.00K	930.00K	-170.00K	-25.00K	3.49M	-11.00K	58.00K	3.30M	1.96M	4.89M	1.00K	14.54M	21.00K	21.05M	14.00K	45.00K	19.11M	51.65M	232.00K	56.90M	-1.30M	26.09M	13.61M
Capital Expenditure	32.00K	0	42.00K	77.00K	9.00K	0	130.00K	138.00K	212.00K	1.10M	1.07M	1.79M	2.23M	2.80M	3.87M	4.63M	2.13M	2.52M	2.53M	1.67M	1.31M	594.00K	1.26M	339.00K	53.00K
Free Cash Flow	-106.00K	-106.00K	-84.00K	-484.00K	-93.00K	-139.00K	-1.38M	-1.43M	-3.01M	-2.85M	-1.67M	-2.50M	-3.61M	-3.64M	-6.38M	-8.86M	-6.37M	-7.99M	-15.54M	-12.31M	-21.82M	-17.03M	-16.13M	-23.94M	-24.80M
FCF to OCF	76.81%	100.00%	200.00%	118.92%	113.41%	100.00%	110.40%	110.66%	107.57%	163.41%	279.87%	351.34%	262.16%	434.13%	253.72%	209.26%	150.18%	146.14%	119.42%	115.65%	106.41%	103.61%	108.49%	101.44%	100.21%

Earnings

Report Date	Oct 24, 2013	Apr 23, 2014	Oct 23, 2014	Apr 25, 2016	Oct 17, 2016	Apr 24, 2017	Oct 4, 2017	Apr 2, 2018	Oct 2, 2018	Apr 30, 2019	Oct 18, 2019	May 6, 2020	Sep 28, 2020	Mar 29, 2021	Apr 22, 2021	Sep 30, 2021	Apr 6, 2022	Sep 30, 2022	Apr 25, 2023	Sep 30, 2024	Jun 6, 2025	Sep 30, 2025
EPS Estimate	-2.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-	-	0.00	-	0.00
EPS Actual	0.00	0.00	0.00	-0.03	-0.04	-0.05	-0.04	-0.06	-0.08	-0.05	-0.04	-0.04	-0.04	0.00	-0.05	-0.04	-0.11	-0.04	-0.12	-0.02	-0.04	-0.04
Surprise	100.00%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	Pre-market	Pre-market	-	Pre-market	-

Key Statistics & Ratios

Market Cap329.01M

Enterprise Value349.47M

Trailing P/E0.00

Forward P/E113.64

PEG Ratio0.00

Price / Sales2911.61

Price / Book141.93

EPS-0.09

Book Value0.006

Revenue (TTM)113.00K

Gross Profit (TTM)113.00K

EBITDA-29.90M

Profit Margin0.00%

Operating Margin-24419.64%

Return on Equity-1965.14%

Return on Assets-62.36%

Shares Outstanding437.63M

Shares Float440.85M

Beta-0.11

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Stock Splits

Jan 26, 20161:100
May 8, 20065:1